Jump to topic
Comprehensive Health Studies Pilot Funding
Information will be posted here when it becomes available.
2022 Comprehensive Health Studies Pilot Awardees
The mission of the new Comprehensive Health Studies (CHS) pilot funding program is to enhance patient-centered, translational sciences by unlocking the complex interactions of genetics, biological processes, socio-economics, and life circumstances to improve the understanding of human health and mechanisms of disease. Novel interdisciplinary, patient-centered translational research is necessary to address the complex health challenges faced by today’s patients and communities.
This CHS funding mechanism is designed to encourage innovative proposals that:
- Leverage current or growing areas of the College of Medicine’s research strengths
- Address health challenges that cannot be addressed by a single scientific discipline within the College of Medicine or Penn State University
- Focus on health priorities/disease areas that affect the communities served by College of Medicine and the Milton S. Hershey Medical Center.
These are designed to seed (up to $10,000) the development of interdisciplinary teams and research projects of up to 12-month duration to facilitate the transformation of ideas from concept into an innovative, team science-based, translational proposal.
Collaborative Pilot Awards
These are designed to support innovative pilot studies, including high-risk, high-reward research that can lead to the submission of external grant proposals (e.g., NIH R21/R01 mechanisms; PCORI). This funding (up to $50,000) will support pilot studies of up to an 18-month period. Priority will be given to proposals from multidisciplinary teams (e.g., faculty from multiple departments and colleges across PSU, community partners, etc.).
Collaborative Program Awards
These awards will support synergistic individual projects (maximum of three) aimed at developing a future external research program proposal such as the NIH P, U, or T mechanisms. This funding (up to $150,000) is intended for principal investigators who currently hold a R-level NIH award, and who are eligible to compete for the NIH P, U, T or similar mechanisms. The funding will support pilot studies for no longer than a two-year period.